A rat model of complete atrioventricular block recapitulates clinical indices of bradycardia and provides a platform to test disease-modifying therapies

Complete atrioventricular block (CAVB) is a life-threatening arrhythmia. A small animal model of chronic CAVB that properly reflects clinical indices of bradycardia would accelerate the understanding of disease progression and pathophysiology, and the development of therapeutic strategies. We sought to develop a surgical model of CAVB in adult rats, which could recapitulate structural remodeling and arrhythmogenicity expected in chronic CAVB. Upon right thoracotomy, we delivered electrosurgical energy subepicardially via a thin needle into the atrioventricular node (AVN) region of adult rats to create complete AV block. The chronic CAVB animals developed dilated and hypertrophied ventricles with preserved systolic functions due to compensatory hemodynamic remodeling. Ventricular tachyarrhythmias, which are difficult to induce in the healthy rodent heart, could be induced upon programmed electrical stimulation in chronic CAVB rats and worsened when combined with β-adrenergic stimulation. Focal somatic gene transfer of TBX18 to the left ventricular apex in the CAVB rats resulted in ectopic ventricular beats within days, achieving a de novo ventricular rate faster than the slow atrioventricular (AV) junctional escape rhythm observed in control CAVB animals. The model offers new opportunities to test therapeutic approaches to treat chronic and severe CAVB which have previously only been testable in large animal models.

[1]  Hee Cheol Cho,et al.  Direct conversion of quiescent cardiomyocytes to pacemaker cells by expression of Tbx18 , 2012, Nature Biotechnology.

[2]  M. Vos,et al.  Vernakalant is devoid of proarrhythmic effects in the complete AV block dog model. , 2013, European journal of pharmacology.

[3]  R. Litwak,et al.  Creating permanent complete heart block by indirect cauterization without atriotomy. , 1977, The American journal of physiology.

[4]  P. Duchêne-Marullaz,et al.  Methods for producing experimental complete atrioventricular block in dogs. , 1985, Journal of pharmacological methods.

[5]  J. Roos‐Hesselink,et al.  Complications of pacemaker therapy in adults with congenital heart disease: a multicenter study. , 2013, International journal of cardiology.

[6]  Mei-xiang Xiang,et al.  Torsade de pointes in a patient with complete atrioventricular block and pacemaker failure, misdiagnosed with epilepsy. , 2015, Journal of electrocardiology.

[7]  D. D. da Cunha,et al.  Acute and chronic observations of complete atrioventricular block in rats , 2014, Laboratory animals.

[8]  F. Gadler,et al.  Outcome in young patients with isolated complete atrioventricular block and permanent pacemaker treatment: A nationwide study of 127 patients. , 2015, Heart rhythm.

[9]  Hee Cheol Cho,et al.  Transcriptional Suppression of Connexin43 by TBX18 Undermines Cell-Cell Electrical Coupling in Postnatal Cardiomyocytes , 2011, The Journal of Biological Chemistry.

[10]  M. Haissaguerre,et al.  Pathophysiology, clinical course, and management of congenital complete atrioventricular block. , 2013, Heart Rhythm.

[11]  B. Prendergast,et al.  Guidelines for the diagnosis, management and prevention of implantable cardiac electronic device infection , 2014, Heart.

[12]  E. Marbán,et al.  Delayed Repolarization Underlies Ventricular Arrhythmias in Rats With Heart Failure and Preserved Ejection Fraction , 2017, Circulation.

[13]  H. Duff,et al.  Complete heart block and sudden death in mice overexpressing calreticulin. , 2001, The Journal of clinical investigation.

[14]  A. Skanes,et al.  Torsades de pointes during complete atrioventricular block: Genetic factors and electrocardiogram correlates. , 2010, The Canadian journal of cardiology.

[15]  Udi Nussinovitch,et al.  Sinoatrial node cardiomyocytes derived from human pluripotent cells function as a biological pacemaker , 2016, Nature Biotechnology.

[16]  M. Valero-Muñoz,et al.  Murine Models of Heart Failure With Preserved Ejection Fraction , 2017, JACC. Basic to translational science.

[17]  G. Gallinghouse,et al.  Development of a model of complete heart block in rats. , 1998, Journal of applied physiology.

[18]  S. Altay,et al.  Pacemaker implantation complication rates in elderly and young patients , 2013, Clinical interventions in aging.

[19]  W. Giles,et al.  Nkx2-5 Pathways and Congenital Heart Disease Loss of Ventricular Myocyte Lineage Specification Leads to Progressive Cardiomyopathy and Complete Heart Block , 2004, Cell.

[20]  慮興源,et al.  A FISHING EXPEDITION , 1983 .

[21]  W. Shimizu,et al.  Transplantation of Mesenchymal Stem Cells Improves Atrioventricular Conduction in a Rat Model of Complete Atrioventricular Block , 2008, Cell transplantation.

[22]  V. Paunescu,et al.  Optimal access to the rat heart by transverse bilateral thoracotomy with double ligature of the internal thoracic arteries. , 2008, Journal of the American Association for Laboratory Animal Science : JAALAS.

[23]  T. Starzl,et al.  Acute Complete Heart Block in Dogs , 1955, Circulation.

[24]  O. Berenfeld,et al.  Reduced Ventricular Arrhythmogeneity and Increased Electrical Complexity in Normal Exercised Rats , 2013, PloS one.

[25]  A. Moorman,et al.  Formation of the Sinus Node Head and Differentiation of Sinus Node Myocardium Are Independently Regulated by Tbx18 and Tbx3 , 2009, Circulation research.

[26]  Joshua I. Goldhaber,et al.  Next-generation pacemakers: from small devices to biological pacemakers , 2018, Nature Reviews Cardiology.

[27]  S. Demolombe,et al.  Early ion-channel remodeling and arrhythmias precede hypertrophy in a mouse model of complete atrioventricular block. , 2011, Journal of molecular and cellular cardiology.

[28]  M. Vos,et al.  The canine model with chronic, complete atrio-ventricular block. , 2008, Pharmacology & therapeutics.

[29]  G. Portugal,et al.  Complete atrioventricular block in acute coronary syndrome: prevalence, characterisation and implication on outcome , 2018, European heart journal. Acute cardiovascular care.

[30]  W. C. Randall,et al.  Gross and microscopic anatomy of the vagal innervation of the rat heart , 1992, The Anatomical record.

[31]  B. Wilkoff,et al.  Cardiac implantable electronic device infections: presentation, management, and patient outcomes. , 2010, Heart rhythm.

[32]  S. Ho,et al.  Anatomic Assessment of Variations in Myocardial Approaches to the Atrioventricular Node , 2012, Journal of cardiovascular electrophysiology.

[33]  Mark A Hlatky,et al.  2012 ACCF/AHA/HRS focused update incorporated into the ACCF/AHA/HRS 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society. , 2013, Circulation.

[34]  Minoru Horie,et al.  Evaluation and management of bradycardia in neonates and children , 2016, European Journal of Pediatrics.

[35]  Hee Cheol Cho,et al.  Biological therapies for cardiac arrhythmias: can genes and cells replace drugs and devices? , 2010, Circulation research.

[36]  S. Nattel,et al.  T-Type Calcium Current Contributes to Escape Automaticity and Governs the Occurrence of Lethal Arrhythmias After Atrioventricular Block in Mice , 2013, Circulation. Arrhythmia and electrophysiology.

[37]  S. Chugh,et al.  Biological pacemaker created by percutaneous gene delivery via venous catheters in a porcine model of complete heart block. , 2012, Heart rhythm.

[38]  A. Moorman,et al.  Formation of the Venous Pole of the Heart From an Nkx2–5–Negative Precursor Population Requires Tbx18 , 2006, Circulation research.

[39]  R. Lee,et al.  Production of chronic atrioventricular block in dogs without thoracotomy. , 1966, Journal of applied physiology.

[40]  T. Starzl,et al.  Chronic Heart Block in Dogs. A Method for Producing Experimental Heart Failure , 1955, Circulation.

[41]  A. Becker,et al.  Morphology of the Human Atrioventricular Node is Age Dependent: A Feature of Potential Clinical Significance , 2000, Journal of cardiovascular electrophysiology.

[42]  L. Ravà,et al.  Twenty years of paediatric cardiac pacing: 515 pacemakers and 480 leads implanted in 292 patients. , 2006, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[43]  E. Omerovic,et al.  Effects of complete heart block on myocardial function, morphology, and energy metabolism in the rat. , 2007, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[44]  S. Kropp,et al.  Lorazepam-Induced Prolongation of the QT Interval in a Patient with Schizoaffective Disorder and Complete AV Block , 2004, Canadian journal of psychiatry. Revue canadienne de psychiatrie.

[45]  Y. Okumura,et al.  Combined effect of disopyramide and erythromycin on ventricular repolarization in dogs with complete atrioventricular block. , 2011, International heart journal.

[46]  D. Escande,et al.  Biological pacemaker engineered by nonviral gene transfer in a mouse model of complete atrioventricular block. , 2008, Molecular therapy : the journal of the American Society of Gene Therapy.

[47]  C. Mavroudis,et al.  An improved in vivo method for atrioventricular node ablation via thoracotomy. , 2010, Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas.

[48]  Yu-Feng Hu,et al.  Biological pacemaker created by minimally invasive somatic reprogramming in pigs with complete heart block , 2014, Science Translational Medicine.